📋 FDA Reference
Philips Intellivue Xds Software
Philips Medizin Systeme Boeblingen
Summary: The Philips IntelliVue XDS Software is a medical device used to facilitate the display and integration of patient monitoring data across different displays in clinical settings. It is primarily utilized by healthcare professionals in hospitals and clinics to ensure accurate patient data management.
FDA Clearance Information
Pathway ?
510(k)
Number ?
K182637 ↗
Decision Date ?
April 26, 2019
Product Code ?
MSX
Device Class ?
Class 2
Evidence ?
419 studies
The Philips IntelliVue XDS Software was cleared through the FDA 510(k) pathway on April 26, 2019. It is manufactured by Philips Medizin Systeme Boeblingen and classified as a Class 2 device under product code MSX.
What It Is
The Philips IntelliVue XDS Software is designed to enhance the functionality of patient monitoring systems by allowing data to be displayed on multiple remote screens. This software integrates with Philips IntelliVue monitors to ensure that patient data is accurately and efficiently managed across different clinical environments. It helps clinicians monitor vital signs and other critical parameters without being confined to a single location.
FDA-Cleared Indications
- Display patient-monitoring information from compatible Philips IntelliVue monitoring systems on additional or remote displays.
- Support access to monitoring data in clinical environments where patient information must be viewed from more than one location.
Clinical Applications
- Viewing vital signs and other patient-monitoring parameters at remote clinical workstations.
- Supporting continuous monitoring in intensive care and other hospital settings.
- Displaying monitoring information during perioperative care when compatible Philips IntelliVue systems are in use.
- Providing clinicians with access to patient-monitoring data without requiring them to remain at the primary monitor.
Practical Considerations
- Compatibility must be confirmed with the installed Philips IntelliVue monitors, software versions, network configuration and display hardware.
- The software depends on the hospital information-technology network and appropriate system configuration; network interruptions may affect remote data display.
- It displays monitoring information but does not replace clinical assessment, the primary patient monitor or established alarm-management procedures.
- This is software rather than an implanted or patient-contact device; MRI compatibility is not determined by the software alone. Any computer, display or monitoring hardware used near an MRI scanner must be separately evaluated under the facility's MRI safety policy.
- Training, cybersecurity controls, software updates and verification of displayed patient identity are important before clinical use.
Related Literature
The linked study examined a data transfer issue with the Philips IntelliVue XDS Software, where patient data could remain on the original display instead of transferring to a new one. This issue was limited to software version H.00.xx or earlier. A software upgrade was identified as a solution to enable automatic data transfer, highlighting the importance of keeping software up-to-date. The study underscores the need for vigilance in software management to prevent data misassociation.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is Philips IntelliVue XDS Software used for?
It is used for displaying and managing patient monitoring data across multiple remote screens in clinical settings.
What specialties typically use this device?
Specialties such as critical care, emergency medicine, and anesthesiology commonly use this device.
What are the FDA-cleared indications?
The software is indicated for displaying and managing patient monitoring data, suitable for continuous monitoring in critical care and surgical settings.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.